Pharmaceutical Business Review—Oct. 31, 2011— Foundation Fighting Blindness Funds Gene Therapy Development
Friday, 04 November 2011
Pharmaceutical Business Review reports on the Foundation’s $8.25 million investment in six gene therapy projects poised for clinical trials within three years.
